283 related articles for article (PubMed ID: 36406250)
1. Engineering white blood cell membrane-camouflaged nanocarriers for inflammation-related therapeutics.
Song W; Jia P; Ren Y; Xue J; Zhou B; Xu X; Shan Y; Deng J; Zhou Q
Bioact Mater; 2023 May; 23():80-100. PubMed ID: 36406250
[TBL] [Abstract][Full Text] [Related]
2. White Blood Cell Membrane-Coated Nanoparticles: Recent Development and Medical Applications.
Wang D; Wang S; Zhou Z; Bai D; Zhang Q; Ai X; Gao W; Zhang L
Adv Healthc Mater; 2022 Apr; 11(7):e2101349. PubMed ID: 34468090
[TBL] [Abstract][Full Text] [Related]
3. Cell Membrane-Camouflaged Nanocarriers with Biomimetic Deformability of Erythrocytes for Ultralong Circulation and Enhanced Cancer Therapy.
Miao Y; Yang Y; Guo L; Chen M; Zhou X; Zhao Y; Nie D; Gan Y; Zhang X
ACS Nano; 2022 Apr; 16(4):6527-6540. PubMed ID: 35426300
[TBL] [Abstract][Full Text] [Related]
4. Engineered Cell Membrane-Derived Nanocarriers: The Enhanced Delivery System for Therapeutic Applications.
Yu B; Xue X; Yin Z; Cao L; Li M; Huang J
Front Cell Dev Biol; 2022; 10():844050. PubMed ID: 35295856
[TBL] [Abstract][Full Text] [Related]
5. Hybrid cell membrane-coated nanoparticles: A multifunctional biomimetic platform for cancer diagnosis and therapy.
Chen HY; Deng J; Wang Y; Wu CQ; Li X; Dai HW
Acta Biomater; 2020 Aug; 112():1-13. PubMed ID: 32470527
[TBL] [Abstract][Full Text] [Related]
6. Cell Membrane-Camouflaged Nanocarriers for Cancer Diagnostic and Therapeutic.
Li S; Liu J; Sun M; Wang J; Wang C; Sun Y
Front Pharmacol; 2020; 11():24. PubMed ID: 32116701
[TBL] [Abstract][Full Text] [Related]
7. Surface modification strategies in translocating nano-vesicles across different barriers and the role of bio-vesicles in improving anticancer therapy.
Tiwari P; Yadav K; Shukla RP; Gautam S; Marwaha D; Sharma M; Mishra PR
J Control Release; 2023 Nov; 363():290-348. PubMed ID: 37714434
[TBL] [Abstract][Full Text] [Related]
8. Cell membrane-camouflaged nanoparticles as drug carriers for cancer therapy.
Xu CH; Ye PJ; Zhou YC; He DX; Wei H; Yu CY
Acta Biomater; 2020 Mar; 105():1-14. PubMed ID: 32001369
[TBL] [Abstract][Full Text] [Related]
9. Silica-Based Nanoparticles for Biomedical Applications: From Nanocarriers to Biomodulators.
Yang Y; Zhang M; Song H; Yu C
Acc Chem Res; 2020 Aug; 53(8):1545-1556. PubMed ID: 32667182
[TBL] [Abstract][Full Text] [Related]
10. Oxygen-Based Nanocarriers to Modulate Tumor Hypoxia for Ameliorated Anti-Tumor Therapy: Fabrications, Properties, and Future Directions.
Li X; Wu Y; Zhang R; Bai W; Ye T; Wang S
Front Mol Biosci; 2021; 8():683519. PubMed ID: 34277702
[TBL] [Abstract][Full Text] [Related]
11. Nature-inspired nanocarriers for improving drug therapy of atherosclerosis.
Ji W; Zhang Y; Deng Y; Li C; Kankala RK; Chen A
Regen Biomater; 2023; 10():rbad069. PubMed ID: 37641591
[TBL] [Abstract][Full Text] [Related]
12. Construction of Biomimetic-Responsive Nanocarriers and their Applications in Tumor Targeting.
Tian X; Shi A; Wu J
Anticancer Agents Med Chem; 2022; 22(12):2255-2273. PubMed ID: 34994336
[TBL] [Abstract][Full Text] [Related]
13. Biointerface engineering nanoplatforms for cancer-targeted drug delivery.
Zhang H; Dong S; Li Z; Feng X; Xu W; Tulinao CMS; Jiang Y; Ding J
Asian J Pharm Sci; 2020 Jul; 15(4):397-415. PubMed ID: 32952666
[TBL] [Abstract][Full Text] [Related]
14. Immune-regulating camouflaged nanoplatforms: A promising strategy to improve cancer nano-immunotherapy.
Chen BQ; Zhao Y; Zhang Y; Pan YJ; Xia HY; Kankala RK; Wang SB; Liu G; Chen AZ
Bioact Mater; 2023 Mar; 21():1-19. PubMed ID: 36017071
[TBL] [Abstract][Full Text] [Related]
15. Engineered Cell Membrane-Camouflaged Nanomaterials for Biomedical Applications.
Guan X; Xing S; Liu Y
Nanomaterials (Basel); 2024 Feb; 14(5):. PubMed ID: 38470744
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in cell membrane-camouflaged nanoparticles for inflammation therapy.
Zhang R; Wu S; Ding Q; Fan Q; Dai Y; Guo S; Ye Y; Li C; Zhou M
Drug Deliv; 2021 Dec; 28(1):1109-1119. PubMed ID: 34121563
[TBL] [Abstract][Full Text] [Related]
17. The clinical regimens and cell membrane camouflaged nanodrug delivery systems in hematologic malignancies treatment.
Liu Y; Yu S; Chen Y; Hu Z; Fan L; Liang G
Front Pharmacol; 2024; 15():1376955. PubMed ID: 38689664
[TBL] [Abstract][Full Text] [Related]
18. Development of white blood cell fragments, during the preparation and storage of platelet concentrates, as measured by using real-time polymerase chain reaction.
Dijkstra-Tiekstra MJ; van der Schoot CE; Pietersz RN; Huijgens PC; van der Meer PF; Reesink HW
Vox Sang; 2004 Nov; 87(4):250-6. PubMed ID: 15585020
[TBL] [Abstract][Full Text] [Related]
19. Engineering Cell Membrane-Based Nanotherapeutics to Target Inflammation.
Yan H; Shao D; Lao YH; Li M; Hu H; Leong KW
Adv Sci (Weinh); 2019 Aug; 6(15):1900605. PubMed ID: 31406672
[TBL] [Abstract][Full Text] [Related]
20. Cell membrane cloaked nanomedicines for bio-imaging and immunotherapy of cancer: Improved pharmacokinetics, cell internalization and anticancer efficacy.
Hussain Z; Rahim MA; Jan N; Shah H; Rawas-Qalaji M; Khan S; Sohail M; Thu HE; Ramli NA; Sarfraz RM; Abourehab MAS
J Control Release; 2021 Jul; 335():130-157. PubMed ID: 34015400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
